FDA approves VisuMax 800 with SMILE pro software for myopia
Click Here to Manage Email Alerts
Key takeaways:
- The FDA approved the VisuMax 800 with SMILE pro software for the treatment of myopia.
- The system is designed to improve workflow and allow for faster surgery.
The FDA approved the VisuMax 800 femtosecond laser with SMILE pro software for the treatment of myopia with or without astigmatism, according to a press release from Carl Zeiss Meditec.
The laser provides “a smaller footprint and compatibility with a variety of patient beds, adapting to the clinical environment to provide cutting-edge technology without compromise,” the company said.
The system is designed to improve workflow during surgery, allowing for the creation of the lenticule in less than 10 seconds due to a faster laser pulse repetition rate of 2 MHz. Features include the CentraLign centration aid, the OcuLign cyclotorsion adjustment and Visulyze user nomograms.
“As part of the Zeiss Medical Ecosystem, this next-generation femtosecond laser system creates data-driven insights to help surgeons manage better treatment paths for patients while supporting each surgeon’s unique practice requirements for greater workflow efficiency and performance,” Euan S. Thomson, PhD, president of ophthalmology strategic business unit and head of the digital business unit for Zeiss Medical Technology, said in the release.
Read more about
Click Here to Manage Email Alerts